- From: Brian Osborne <osborne1@optonline.net>
- Date: Wed, 22 Mar 2006 16:20:47 -0500
- To: eneumann@teranode.com, "public-semweb-lifesci@w3.org" <public-semweb-lifesci@w3.org>
Eric, I'd be happy to work on this or related use cases or projects. Brian G., I know you're interested in working with D2RQ, you've already noted that one of the significant technical undertakings in this proposal is making SMID's data, a Mysql dump, available as RDF. And you also know that D2RQ wraps Mysql so... Brian O On 3/22/06 1:26 PM, "Eric Neumann" <eneumann@teranode.com> wrote: > > > Brian, > > I think this is an excellent use-case topic, and one that is timely since > I had just met with Scott Eliasof of the Broad Institute, who is advancing > their chemo-genomics platform and building on ChemBank as well. > > I have forwarded your use-case to him, and hope his team can lend some > support to your proposal. > > best, > Eric > > --- Brian Osborne <osborne1@optonline.net> wrote: > >> semweb-lifesci, >> >> Iıve added to a page to BioRDF/Tasks that describes >> an interesting use case, >> all IMHO of course: >> >> http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/Tasks/Using_SW_Technologies_t >> o_Find_Small_Molecules_that_Bind_to_Proteins >> >> My perspective on BioRDF generally is that weıre >> tasked to create useful RDF >> or to use RDF, this particular case would actually >> do both. There are some >> formal problems with the proposal, discussed in a >> ³Critique² section at the >> bottom. If thereıs sufficient interest Iıd be happy >> to provide more detail, >> do some sort of coding, or both. >> >> Brian O. >> > > > Eric Neumann > Senior Director Product Strategy > Teranode Corporation > 83 South King Street, Suite 800 > Seattle, WA 98104 > +1 (781)856-9132 > www.teranode.com >
Received on Wednesday, 22 March 2006 21:21:55 UTC